TeenScreen
A mental health screening program for adolescents
TeenScreen was a national mental health screening program in the United States aimed at identifying mental health issues in adolescents. The program was developed by the Columbia University's Division of Child and Adolescent Psychiatry and was implemented in schools, clinics, and other community settings.
Overview
TeenScreen was designed to identify teenagers who might be at risk for mental health disorders such as depression, anxiety, and suicidal ideation. The program used a questionnaire to assess the mental health status of adolescents, and those who were identified as at risk were referred for further evaluation by a mental health professional.
History
The TeenScreen program was initiated in the late 1990s and gained national attention in the early 2000s. It was part of a broader movement to address the mental health needs of young people in the United States. The program was supported by various mental health advocacy groups and received funding from both public and private sources.
Implementation
TeenScreen was implemented in various settings, including schools, community health centers, and juvenile justice facilities. The screening process was voluntary, and parental consent was required for participation. The program aimed to reduce the stigma associated with mental health issues and to promote early intervention.
Controversy
Despite its goals, TeenScreen faced criticism from some groups who were concerned about privacy issues and the potential for over-diagnosis and over-medication of adolescents. Critics argued that the program could lead to unnecessary labeling of young people and that it might infringe on parental rights.
Closure
In 2012, the TeenScreen program was discontinued. The decision to end the program was attributed to a lack of sustainable funding and the challenges of implementing the program on a national scale. However, the legacy of TeenScreen continues to influence discussions about adolescent mental health screening and early intervention.
Related pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD